Voltaren Market Report 2025 (Global Edition)

Global Voltaren Market Report 2024 Market Size Split by Product Type Outlook: (Gel, Tablets, Patches, Others), by Application Outlook: (Pain Relief, InfHomecaren Reduction, Others), by Distribution Ch...

Voltaren Market Report Description

We have various report editions of Voltaren Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Voltaren Market

The competitive landscape of the Voltaren market is dominated by major pharmaceutical companies like GlaxoSmithKline, Novartis, and Pfizer, with strong brand recognition and established distribution channels. These players compete by offering effective pain relief solutions, leveraging research and development for product innovations. Additionally, generic drug manufacturers like Mylan and Teva also contribute to competition by providing cost-effective alternatives. Companies are increasingly focusing on expanding their market presence through e-commerce platforms and strategic marketing to reach a broader consumer base.

In January 2023, Yaral Pharma Inc. launched a diclofenac epolamine topical system 1.3%, the authorized generic of IBSA Pharma's Flector (diclofenac epolamine) topical system in the United States.

(Source:https://www.businesswire.com/news/home/20221230005209/en/Yaral-Pharma-Launches-Diclofenac-Epolamine-Topical-System-1.3)

In December 2022, Lupin Limited launched an authorized generic PENNSAI (Diclofenac Sodium Topical Solution), 2% w/w of Horizon Pharma Therapeutics.

(Source:https://www.lupin.com/lupin-launches-authorized-generic-version-of-pennsaid-2-w-w-in-the-united-states/)

In February 2022, Lumiera Health Inc. launched its Awaye pain relief cream in the United States market. Awaye relieves acute and chronic pain by exploiting the CB2 receptors of the endocannabinoid system.

(Source:https://www.newswire.ca/news-releases/lumiera-health-begins-sales-of-awaye-tm-pain-relief-cream-and-launches-direct-to-consumer-e-commerce-platform-866336867.html)

Top Companies Market Share in Voltaren Industry: (In no particular order of Rank)

• GlaxoSmithKline (GSK)
• Novartis AG
• Pfizer Inc.
• Johnson & Johnson
• Mylan N.V. (Viatris)
• Sanofi
• Bayer AG
• AbbVie Inc.
• Takeda Pharmaceutical Company
• Amgen Inc.
• Reckitt Benckiser Group
• Astellas Pharma Inc.
• Boehringer Ingelheim
• Teva Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Voltaren Market

Which Region Dominates the Voltaren Market in 2024?

According to Cognitive Market Research, North America currently dominates the Voltaren market, and the region is expected to have significant growth during the projected period. This is due to a high prevalence of musculoskeletal disorders, such as arthritis, among the aging population. Increased awareness of pain management options, including effective over-the-counter solutions like Voltaren, has driven demand. Additionally, well-established healthcare infrastructure, easy access to pharmacies, and a growing preference for topical treatments further support market growth. Strong distribution networks, including online platforms, and the product's proven effectiveness in managing chronic pain have contributed to Voltaren’s dominant market position in North America.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The Asia Pacific region is growing at the fastest CAGR in the Voltaren market due to the rising prevalence of musculoskeletal disorders, especially in the aging population. Increasing healthcare awareness, coupled with growing disposable incomes, has driven demand for effective over-the-counter pain relief products like Voltaren. Additionally, expanding access to healthcare services, improvements in retail infrastructure, and the shift toward non-invasive treatments further fuel market growth. E-commerce platforms also contribute to Voltaren’s increasing availability across the region.

The current report Scope analyzes Voltaren Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Voltaren

According to Cognitive Market Research, the global Voltaren market size was estimated at USD 5521.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 2208.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Voltaren market with a market size of USD 1742.59 million in 2024 and is projected to grow at a CAGR of 2.5% during the forecast period. The U.S. market's increasing awareness of its benefits in pain management, particularly for joint and muscle pain is driving the Voltaren market.
• The Canada Voltaren market had a market share of USD 265.03 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. Canada’s aging population is driving the Voltaren market.
• The Mexico Voltaren market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 200.98 million in 2024.

Europe Voltaren

According to Cognitive Market Research, the global Voltaren market size was estimated at USD 5521.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1656.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.0% from 2024 to 2031.

• The United Kingdom Voltaren market had a market share of USD 278.28 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. In the UK, Voltaren sales witness an upswing due to increasing prevalence of musculoskeletal disorders, such as arthritis and joint pain, which are more common in the aging population.
• The France Voltaren market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 152.39 million in 2024.
• According to Cognitive Market Research, the German Voltaren market size was valued at USD 327.98 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. In Germany, Voltaren surged due to the increased focus of the manufacturers and major market players.
• The Italy Voltaren market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 142.45 million in 2024.
• The Russia Voltaren market is projected to witness growth at a CAGR of 2.0% during the forecast period, with a market size of USD 256.75 million in 2024.
• The Spain Voltaren market is projected to witness growth at a CAGR of 2.1% during the forecast period with a market size of USD 135.83 million in 2024
• The Luxembourg Voltaren market is projected to witness growth at a CAGR of 3.1% during the forecast period, with a market size of USD 51.35 million in 2024.
• The Portugal Voltaren market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 34.79 million in 2024.
• The Greece Voltaren market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 19.88 million in 2024.
• The Rest of Europe's Voltaren market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 256.75 million in 2024.

Asia Pacific Voltaren

According to Cognitive Market Research, the global Voltaren market size was estimated at USD 5521.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1269.95 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5%from 2024 to 2031.

• According to Cognitive Market Research, the China Voltaren market size was valued at USD 571.48 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Voltaren surged in China due to rising healthcare awareness and increasing incidence of chronic pain conditions like arthritis, particularly among the aging population.
• The Japan Voltaren market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 175.25 million in 2024.
• The India Voltaren market had a market share of USD 152.39 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. India's expanding access to healthcare products is driving Voltaren market.
• The South Korean Voltaren market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 126.99 million in 2024.
• The Australian Voltaren market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 66.04 million in 2024.
• The South East Asia Voltaren market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 87.63 million in 2024.
• The Rest of Asia Pacific Voltaren market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 90.17 million in 2024.

South America Voltaren

According to Cognitive Market Research, the global Voltaren market size was estimated at USD 5521.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 276.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Voltaren market size was valued at USD 118.16 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. Voltaren flourished in Brazil due to rising awareness of joint and muscle pain management, especially among the aging population.
• Argentina's Voltaren market had a market share of USD 46.38 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. Argentina's expanding healthcare access is driving the Voltaren market.
• Colombia Voltaren market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 24.57 million in 2024.
• Peru Voltaren market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 22.64 million in 2024.
• Chile Voltaren market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 19.88 million in 2024.
• The Rest of Latin America's Voltaren market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 44.45 million in 2024.

Middle East and Africa Voltaren

According to Cognitive Market Research, the global Voltaren market size was estimated at USD 5521.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 110.43 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031..

• The GCC Countries Voltaren market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 47.26 million in 2024. Voltaren sales flourish due to the presence of major market players.
• The Egypt Voltaren market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 11.60 million in 2024.
• The South Africa Voltaren market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 17.45 million in 2024. Voltaren sales flourished in South Africa due to increasing awareness of chronic pain management, particularly for conditions like arthritis and musculoskeletal disorders.
• The Turkey Voltaren market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 9.50 million in 2024.
• The Nigeria Voltaren market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 11.60 million in 2024.
• The Rest of the MEA Voltaren market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 13.03 million in 2024.

Voltaren Market Analysis

How are Segments Performing in the Global Voltaren Market?

Voltaren Market Product Segment Analysis

According to Cognitive Market Research, Gel are likely to dominate the Voltaren Market over the forecast period. The gel product type captured the largest market share in the Voltaren market due to its ease of application and fast absorption, offering targeted pain relief. Voltaren Gel is preferred for localized treatment of musculoskeletal disorders like arthritis and joint pain, providing quick and effective relief with minimal side effects. The non-greasy formula, coupled with consumer preference for non-invasive treatments, further boosts its popularity. Its widespread availability in pharmacies and online platforms has also contributed to its market dominance.

The tablets product type is growing at the highest CAGR in the Voltaren market due to increasing consumer preference for convenient, oral pain relief options. Tablets offer ease of use, particularly for individuals who require consistent pain management for conditions like arthritis and back pain. As the demand for non-prescription pain relievers rises, Voltaren tablets provide a simple solution for those seeking systemic pain relief. Additionally, the product’s accessibility in various regions and the expanding retail network contribute to its rapid growth.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Voltaren Industry. Request a Free Sample PDF!

Voltaren Market Application Segment Analysis

According to Cognitive Market Research, the Pain Relief segment holds the largest share of the market. The pain relief application captured the largest market share in the Voltaren market due to its effectiveness in treating a wide range of pain conditions, particularly musculoskeletal disorders like arthritis, joint pain, and muscle strains. Voltaren’s active ingredient, diclofenac, provides targeted relief, making it a preferred choice for consumers seeking non-invasive treatments. The growing prevalence of chronic pain conditions, along with increasing awareness of Voltaren’s benefits, has further driven demand in the pain relief segment, solidifying its market dominance.

The "In-home care reduction" application is growing at the highest CAGR in the Voltaren market due to the increasing trend of self-care and home-based pain management. Consumers are increasingly opting for over-the-counter pain relief products like Voltaren for managing chronic pain, reducing the need for in-person medical consultations or treatments. This shift is driven by convenience, accessibility, and the growing adoption of non-invasive solutions. Voltaren's topical application aligns well with this trend, offering effective pain relief in the comfort of home.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Voltaren Distribution Channel Outlook: Segment Analysis

Voltaren Market Distribution Channel Segment Analysis

According to Cognitive Market Research, The Pharmacies segment holds the largest market share. The pharmacies distribution channel captured the largest market share in the Voltaren market due to the widespread availability and trusted accessibility of the product in physical retail stores. Pharmacies are primary points of sale for over-the-counter medications, providing consumers with the convenience of purchasing Voltaren without a prescription. Additionally, pharmacists play a key role in recommending the product for pain relief, further driving its popularity. The extensive network of pharmacies ensures Voltaren's reach and availability, supporting its market dominance.

The online stores distribution channel is growing at the highest CAGR in the Voltaren market due to the increasing preference for convenient, at-home shopping. Consumers are increasingly turning to e-commerce platforms for purchasing pain relief products like Voltaren due to ease of access, home delivery, and often lower prices. The growth of online pharmacies and e-commerce giants has expanded Voltaren's reach, making it more accessible to a wider audience, including those in remote or underserved areas.

• Pharmacies
• Online Stores
• Supermarkets/Hypermarkets
• Others

Voltaren End-User Outlook: Segment Analysis

Voltaren Market End-User Segment Analysis

According to Cognitive Market Research, The Hospitals segment holds the largest market share. The hospitals end-user segment captured the largest market share in the Voltaren market due to the critical role hospitals play in treating patients with severe or chronic pain conditions, such as arthritis or post-surgery pain. Voltaren, particularly in injectable or prescribed forms, is frequently used in hospital settings for effective pain management. Additionally, healthcare professionals often recommend Voltaren for its proven efficacy, further driving its use in hospitals. The trust in healthcare institutions and their extensive reach contributes to Voltaren’s dominance in this segment.

The clinics end-user segment is growing at the highest CAGR in the Voltaren market due to the increasing preference for outpatient care and quick, targeted pain relief treatments. Clinics offer accessible and cost-effective pain management solutions for conditions like arthritis and muscle pain. Voltaren’s topical formulations, such as gels and creams, are commonly recommended in clinics for localized pain relief. The growing number of specialized pain clinics, along with greater awareness of Voltaren’s benefits, is driving its demand in this segment.

• Hospitals
• Clinics
• Homecare
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion